EUVIMEDEUVIMED entdecken
Fallbericht

Fibrosing interstitial lung disease as a risk factor for lung cancer: a review of the literature and clinical case report

I.N. Trofimenko, B.A. Chernyak, M.S. Nashatyreva

Journal of Respiratory Medicine · 2025

DOI: 10.17116/respmed2025102151 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Journal of Respiratory Medicine, 2025. Verfasst von I.N. Trofimenko und 2 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fibrosing lung diseases represent a heterogeneous group of interstitial lung diseases (ILD) characterised by radiological signs of fibrosis with a progressive course in 13—40% of cases. Lung fibrosis can be associated with lung cancer, significantly impacting disease survival. Persistent pulmonary fibrosis increases a patient’s risk of developing lung cancer. Progressive pulmonary fibrosis (PPF) and lung cancer share common molecular genetic links and risk factors including male gender, smoking, occupational/environmental exposures, low pulmonary function and rapid annual decline in forced vital capacity. Clinical studies confirm that in 75.5% of patients with usual interstitial pneumonia (UIP), lung cancer is found in the subpleural areas of the lower lobes, which corresponds to the typical distribution of fibrotic changes in UIP. Whereas, in patients with other ILD and histology lung cancer is mainly (68.1%) located in the upper lobes. The present observation of chronic hypersensitivity pneumonitis (CHP) with PPF is a clinical illustration confirming the relationship between fibrosing CHP and lung cancer. The difficulties of early diagnosis are due to the unspecific of the clinical and radiological features, which may be a manifestation of both the progression of fibrosing lung disease and the development of lung cancer. Lung cancer is one of the most frequent comorbidities in patients with PPF and requires early diagnosis.

Zitieren

APA

Trofimenko, I., Chernyak, B., & Nashatyreva, M. (2025). Fibrosing interstitial lung disease as a risk factor for lung cancer: a review of the literature and clinical case report. Journal of Respiratory Medicine. https://doi.org/10.17116/respmed2025102151

Vancouver

Trofimenko I, Chernyak B, Nashatyreva M. Fibrosing interstitial lung disease as a risk factor for lung cancer: a review of the literature and clinical case report. Journal of Respiratory Medicine. 2025. doi:10.17116/respmed2025102151

BibTeX
@article{Trofimenko2025,
  author = {Trofimenko, I.N. and Chernyak, B.A. and Nashatyreva, M.S.},
  title = {Fibrosing interstitial lung disease as a risk factor for lung cancer: a review of the literature and clinical case report},
  journal = {Journal of Respiratory Medicine},
  year = {2025},
  doi = {10.17116/respmed2025102151}
}
Kostenlos starten →